
Accolade ACCD
Quarterly report 2024-Q4
added 01-10-2025
Accolade DSO Ratio 2011-2026 | ACCD
Annual DSO Ratio Accolade
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 9.76 | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 9.76 | 9.76 | 9.76 |
Quarterly DSO Ratio Accolade
| 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 20.4 | 17.8 | 17.4 | - | 20.8 | 21 | 22.5 | - | 22.1 | 23.5 | 22.9 | - | 20.5 | 6.57 | 8.39 | 18.8 | 31 | 16.2 | 4.05 | 0.37 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 31 | 0.37 | 17.3 |
DSO Ratio of other stocks in the Health information services industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
American Well Corporation
AMWL
|
89 | $ 5.63 | 3.11 % | $ 90.3 M | ||
|
Cerner Corporation
CERN
|
73.8 | - | - | $ 27.9 B | ||
|
Computer Programs and Systems
CPSI
|
59.7 | - | 4.4 % | $ 133 M | ||
|
Covetrus
CVET
|
39.4 | - | - | $ 2.94 B | ||
|
Castlight Health, Inc.
CSLT
|
79 | - | -7.28 % | $ 227 M | ||
|
HMS Holdings Corp.
HMSY
|
144 | - | - | $ 3.29 B | ||
|
Inovalon Holdings, Inc.
INOV
|
94.4 | - | - | $ 6.37 B | ||
|
iCAD
ICAD
|
127 | - | - | $ 102 M | ||
|
1Life Healthcare
ONEM
|
50.2 | - | - | $ 3.37 B | ||
|
Akerna Corp.
KERN
|
7.62 | - | - | $ 161 M | ||
|
HealthStream
HSTM
|
40.4 | $ 21.95 | -0.45 % | $ 667 M | ||
|
Allscripts Healthcare Solutions
MDRX
|
81.9 | - | -10.39 % | $ 886 M | ||
|
Evolent Health
EVH
|
210 | $ 3.33 | -6.34 % | $ 312 M | ||
|
HealthEquity
HQY
|
140 | $ 80.18 | -1.2 % | $ 6.86 B | ||
|
MTBC
MTBC
|
40.6 | - | -0.58 % | $ 51.7 M | ||
|
Change Healthcare
CHNG
|
87 | - | - | $ 9.03 B | ||
|
Omnicell
OMCL
|
83.4 | $ 42.37 | 2.02 % | $ 1.95 B | ||
|
GoodRx Holdings
GDRX
|
66.7 | $ 2.29 | 4.82 % | $ 883 M | ||
|
Health Catalyst
HCAT
|
69.9 | $ 1.89 | -3.33 % | $ 114 M | ||
|
So-Young International
SY
|
-6.34 K | $ 2.93 | 1.74 % | $ 233 M | ||
|
Progyny
PGNY
|
292 | $ 17.49 | -1.69 % | $ 1.5 B | ||
|
Premier
PINC
|
139 | - | - | $ 2.33 B | ||
|
Teladoc Health
TDOC
|
29.4 | $ 5.09 | -0.88 % | $ 897 M | ||
|
10x Genomics
TXG
|
64.6 | $ 22.16 | -0.94 % | $ 2.6 B | ||
|
Veeva Systems
VEEV
|
120 | $ 193.88 | 2.87 % | $ 31.1 B | ||
|
R1 RCM
RCM
|
27.5 | - | - | $ 3.81 B | ||
|
SCWorx Corp.
WORX
|
41.4 | $ 0.13 | -4.99 % | $ 190 K | ||
|
NantHealth
NH
|
32 | - | -46.64 % | $ 10.4 M | ||
|
OptimizeRx Corporation
OPRX
|
149 | $ 7.53 | -4.32 % | $ 129 M | ||
|
NextGen Healthcare
NXGN
|
51.6 | - | - | $ 1.6 B | ||
|
Phreesia
PHR
|
59.5 | $ 12.12 | -4.04 % | $ 661 M | ||
|
Schrödinger
SDGR
|
227 | $ 12.82 | -2.32 % | $ 942 M | ||
|
Zhongchao
ZCMD
|
116 | $ 1.67 | 0.04 % | $ 8.69 M | ||
|
Signify Health
SGFY
|
272 | - | -0.02 % | $ 7.21 B | ||
|
Streamline Health Solutions
STRM
|
59.4 | - | - | $ 21.4 M | ||
|
Tabula Rasa HealthCare
TRHC
|
24.8 | - | - | $ 255 M |